Fenfluramine (Ponderax) in the treatment of obese psychiatric out-patients.
D001008:Anxiety Disorders / Q000150:complications; D001067:Appetite Depressants / Q000008:administration & dosage*; D001835:Body Weight; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced / Q000150:complications; D003967:Diarrhea / Q000139:chemically induced; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage / Q000009:adverse effects; D005461:Fluorine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000150:complications*; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010554:Personality Disorders / Q000150:complications; D010627:Phenethylamines / Q000008:administration & dosage*; D010919:Placebos; D013223:Statistics as Topic
D001067:Appetite Depressants; D010627:Phenethylamines; D010919:Placebos; D005461:Fluorine; D005277:Fenfluramine